Literature DB >> 1475624

Serum carcinoembryonic antigen in relation to survival, DNA ploidy pattern, and recurrent disease in 406 colorectal carcinoma patients.

G I Meling1, T O Rognum, O P Clausen, O Børmer, O C Lunde, E Schlichting, O P Grüner, J Hognestad, E Trondsen, O Havig.   

Abstract

Serum carcinoembryonic antigen (CEA) levels in relation to survival, flow cytometric DNA ploidy pattern, Dukes stage, and recurrent disease was prospectively evaluated in 406 patients with colorectal carcinoma. In 246 patients (61%) the carcinomas were DNA aneuploid. Increased preoperative CEA levels (> 5 micrograms/l) were found in 151 of 363 evaluable patients (42%). Dukes stage-B patients with preoperative CEA elevation showed significantly poorer prognosis than those with normal CEA values (p = 0.001). A weak but significant correlation was found between preoperative CEA level and Dukes stage (Kendall's tau = 0.25, p < 0.01). Of 50 evaluable patients with clinical recurrence and postoperative normal or normalized CEA levels, 28 (56%) had a rise in CEA before or at the time of clinical recurrence. The sensitivity of the CEA test for primary and for recurrent disease was not significantly different in the DNA aneuploid and the DNA near-diploid groups.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1475624     DOI: 10.3109/00365529209028139

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  4 in total

1.  Incorporation of serum carcinoembryonic antigen levels into the prognostic grouping system of colon cancer.

Authors:  Heita Ozawa; Kenjiro Kotake; Miki Hosaka; Akira Hirata; Yusuke Nakagawa; Shin Fujita; Kenichi Sugihara
Journal:  Int J Colorectal Dis       Date:  2017-02-09       Impact factor: 2.571

2.  Clinical presentation predicts the outcome of patients with colon cancer.

Authors:  Offir Ben-Ishay; Zvi Peled; Amira Othman; Eran Brauner; Yoram Kluger
Journal:  World J Gastrointest Surg       Date:  2013-04-27

Review 3.  Blood CEA levels for detecting recurrent colorectal cancer.

Authors:  Brian D Nicholson; Bethany Shinkins; Indika Pathiraja; Nia W Roberts; Tim J James; Susan Mallett; Rafael Perera; John N Primrose; David Mant
Journal:  Cochrane Database Syst Rev       Date:  2015-12-10

4.  Strong HLA-DR expression in large bowel carcinomas is associated with good prognosis.

Authors:  S N Andersen; T O Rognum; E Lund; G I Meling; S Hauge
Journal:  Br J Cancer       Date:  1993-07       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.